CNBC
@CNBC
First in business worldwide.
Joined February 2009
820 Following 6.2M Followers
Novartis shares tanked 10% on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial, its third drug trial setback in a week.
Check out CNBC's analysis of this breaking story:
Show more
